Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications.
Journal
The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
23
05
2018
revised:
03
01
2019
accepted:
04
01
2019
pubmed:
8
4
2019
medline:
17
6
2020
entrez:
8
4
2019
Statut:
ppublish
Résumé
Stroke represents a massive public health problem. Carotid atherosclerosis plays a fundamental part in the occurence of ischaemic stroke. European and US guidelines for prevention of stroke in patients with carotid plaques are based on quantification of the percentage reduction in luminal diameter due to the atherosclerotic process to select the best therapeutic approach. However, better strategies for prevention of stroke are needed because some subtypes of carotid plaques (eg, vulnerable plaques) can predict the occurrence of stroke independent of the degree of stenosis. Advances in imaging techniques have enabled routine characterisation and detection of the features of carotid plaque vulnerability. Intraplaque haemorrhage is accepted by neurologists and radiologists as one of the features of vulnerable plaques, but other characteristics-eg, plaque volume, neovascularisation, and inflammation-are promising as biomarkers of carotid plaque vulnerability. These biomarkers could change current management strategies based merely on the degree of stenosis.
Identifiants
pubmed: 30954372
pii: S1474-4422(19)30035-3
doi: 10.1016/S1474-4422(19)30035-3
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
559-572Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.